Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Celanese Corp (NY: CE )

154.97 -1.08 (-0.69%)
Streaming Delayed Price Updated: 11:41 AM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 83,827
Open 156.05
Bid (Size) 154.94 (1)
Ask (Size) 155.16 (4)
Prev. Close 156.05
Today's Range 154.39 - 157.11
52wk Range 99.44 - 172.16
Shares Outstanding 110,830,000
Dividend Yield 1.81%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Celanese Announces Kim K.W. Rucker as New Lead Independent Director
From Celanese Corporation
Via Business Wire
Celanese to Hold First Quarter Earnings Conference Call on May 9, 2024
From Celanese Corporation
Via Business Wire

Performance

YTD
+0.16%
+0.16%
1 Month
-7.71%
-7.71%
3 Month
+5.92%
+5.92%
6 Month
+33.40%
+33.40%
1 Year
+46.64%
+46.64%

More News

Read More
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
From Celanese Corporation
Via Business Wire
Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention
From Celanese Corporation
Via Business Wire
How Is The Market Feeling About Celanese?
Via Benzinga
A Closer Look at 11 Analyst Recommendations For Celanese
Via Benzinga
$1000 Invested In Celanese 15 Years Ago Would Be Worth This Much Today
Via Benzinga
Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain
From Celanese Corporation
Via Business Wire
9 Analysts Assess Celanese: What You Need To Know
Via Benzinga
Celanese Achieves ISCC CFC Certification for Low Carbon CCU Methanol
From Celanese Corporation
Via Business Wire
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
From Celanese Corporation
Via Business Wire
Here's How Much $1000 Invested In Celanese 15 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About Celanese?
Via Benzinga
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
Via ACCESSWIRE
Celanese Demonstrates Strong Performance and Increased Profits, Maximizing Returns for Shareholders
Via Benzinga
Celanese Announces Commercial Launch of Glaukos' iDose® TR (Travoprost Intracameral Implant) Using Celanese's VitalDose® Ethylene Vinyl Acetate (EVA)
From Celanese Corporation
Via Business Wire
Timothy Go Elected to Celanese Board of Directors
From Celanese Corporation
Via Business Wire
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
Via Benzinga
Celanese Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
Via Benzinga
Recap: Celanese Q4 Earnings
Via Benzinga
Celanese Upgrade 'Reflects Progress' As Debt Overhang Is Poised To Wane: Analyst
Via Benzinga
7 Earnings Losers With a Shot at a Strong Comeback
Via InvestorPlace
Wells Fargo Maintains Overweight Rating for Celanese: Here's What You Need To Know
Via Benzinga
Celanese Corporation Reports Full Year 2023 and Fourth Quarter Earnings
From Celanese Corporation
Via Business Wire
Earnings Scheduled For February 20, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.